• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Biogen Idec Inc

+ Add to Watchlist

BIIB:US

309.070 USD 17.700 5.42%

As of 17:20:00 ET on 10/22/2014.

Snapshot for Biogen Idec Inc (BIIB)

Open: 300.000 Day's Range: 290.850 - 314.950 Volume: 7,066,545
Previous Close: 326.770 52wk Range: 230.250 - 358.890 1-Yr Rtn: +23.33%

Stock Chart for BIIB

No chart data available.
  • BIIB:US 309.070
  • 1D
  • 1M
  • 1Y
326.770
Interactive BIIB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BIIB

Current P/E Ratio (ttm) 29.9597
Estimated P/E(12/2014) 23.4690
Relative P/E vs. SPX 1.7218
Earnings Per Share (USD) (ttm) 10.3300
Est. EPS (USD) (12/2014) 13.1940
Est. PEG Ratio 1.3082
Market Cap (M USD) 73,083.24
Shares Outstanding (M) 236.14
30 Day Average Volume 1,269,951
Price/Book (mrq) 6.9970
Price/Sale (ttm) 8.0955
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/22/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BIIB

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BIIB

Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products address diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease, and psoriasis.

George A ScangosChief Executive OfficerSusan H AlexanderExec VP/Chief Legal Ofcr/Secy
Paul J ClancyExec VP:Finance/CFOAdriana Karaboutis "Andi"Exec VP:Tech & Bus Solutions
More Company Profile & Key Executives for BIIB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil